These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12919492)

  • 21. Topiramate.
    Glauser TA
    Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypohidrosis related to the administration of topiramate to children.
    Arcas J; Ferrer T; Roche MC; Martínez-Bermejo A; López-Martín V
    Epilepsia; 2001 Oct; 42(10):1363-5. PubMed ID: 11737174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
    Mohamed K; Appleton R; Rosenbloom L
    Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First break of mania associated with topiramate treatment.
    Schlatter FJ; Soutullo CA; Cervera-Enguix S
    J Clin Psychopharmacol; 2001 Aug; 21(4):464-6. PubMed ID: 11476138
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversible language regression as an adverse effect of topiramate treatment in children.
    Gross-Tsur V; Shalev RS
    Neurology; 2004 Jan; 62(2):299-300. PubMed ID: 14745074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of topiramate in children and adolescents.
    Reith D; Burke C; Appleton DB; Wallace G; Pelekanos J
    J Paediatr Child Health; 2003 Aug; 39(6):416-9. PubMed ID: 12919493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate for intractable childhood epilepsy.
    Moreland EC; Griesemer DA; Holden KR
    Seizure; 1999 Feb; 8(1):38-40. PubMed ID: 10091847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of topiramate in children.
    Levisohn PM
    J Child Neurol; 2000; 15 Suppl 1():S22-6. PubMed ID: 11218053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate as a new antiepileptic drug in epileptic children in Iran.
    Fallah R
    Indian J Pediatr; 2006 Dec; 73(12):1073-5. PubMed ID: 17202632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate induced manic episode.
    Jochum T; Bär KJ; Sauer H
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):208-9. PubMed ID: 12122191
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psychosis following treatment with topiramate].
    Verhoeven WM; Boermans JA; van der Heijden FM; Tuinier S
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2093-5. PubMed ID: 12448965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of topiramate in the treatment of focal epilepsy in children].
    Kremenchugskaia MR; Globa OV; Kuzenkova LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):33-8. PubMed ID: 24430032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of topiramate on attention.
    Burton LA; Harden C
    Epilepsy Res; 1997 Apr; 27(1):29-32. PubMed ID: 9169288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of being seizure free: topiramate and psychopathology in epilepsy.
    Mula M; Trimble MR
    Epilepsy Behav; 2003 Aug; 4(4):430-4. PubMed ID: 12899865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate monotherapy for juvenile myoclonic epilepsy.
    Liu J; Wang LN; Wang YP
    Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Child with recently diagnosed epilepsy. Which antiepileptic for first-line therapy?].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():112. PubMed ID: 14579506
    [No Abstract]   [Full Text] [Related]  

  • 40. Topiramate: new indication. Single-agent therapy in refractory epilepsy: for a few patients only.
    Prescrire Int; 2004 Oct; 13(73):165-7. PubMed ID: 15499695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.